Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Asthma, Bronchial

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Asthma, Bronchial in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Research Excerpts

ExcerptRelevanceReference
"When neostigmine is used to reverse muscle relaxants in patients with asthma without signs of airway inflammation, asthma attack is occasionally encountered."3.78Effects of neostigmine on bronchoconstriction with continuous electrical stimulation in rats. ( Ishii, K; Makita, T; Nishioka, K; Shibata, O; Sumikawa, K; Tsuda, A, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, K1
Shibata, O1
Nishioka, K1
Tsuda, A1
Makita, T1
Sumikawa, K1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Asthma, Bronchial

ArticleYear
Effects of neostigmine on bronchoconstriction with continuous electrical stimulation in rats.
    Journal of anesthesia, 2012, Volume: 26, Issue:1

    Topics: Animals; Asthma; Bronchoconstriction; Electric Stimulation; Male; Neostigmine; Parasympathomimetics;

2012